| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0007 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |